Complications of Guillain-Barre syndrome

被引:12
|
作者
Wang, Ying [1 ]
Zhang, Hong-Liang [1 ,2 ]
Wu, Xiujuan [1 ]
Zhu, Jie [1 ,2 ]
机构
[1] Jilin Univ, Dept Neurol, Hosp 1, Ctr Neurosci, Changchun 130023, Peoples R China
[2] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden
基金
瑞典研究理事会; 中国国家自然科学基金;
关键词
short-term; long-term; Guillain-Barre syndrome; peripheral nervous system; complication; REVERSIBLE ENCEPHALOPATHY SYNDROME; MECHANICAL VENTILATION; GANGLIOSIDE; THERAPY; PATIENT; IVIG; PATHOGENESIS; PREVALENCE; ANTIBODIES; NEUROPATHY;
D O I
10.1586/1744666X.2016.1128829
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Guillain-Barre syndrome (GBS) is an immune-mediated disorder in the peripheral nervous system with a wide spectrum of complications. A good understanding of the complications of GBS assists clinicians to recognize and manage the complications properly thereby reducing the mortality and morbidity of GBS patients. Herein, we systemically review the literature on complications of GBS, including short-term complications and long-term complications. We summarize the frequency, severity, clinical manifestations, managements and possible mechanisms of different kinds of complications, and point out the flaws of current studies as well as demonstrate the further investigations needed.
引用
收藏
页码:439 / 448
页数:10
相关论文
共 50 条
  • [31] Genetic basis of Guillain-Barre syndrome
    Khanmohammadi, Shaghayegh
    Malekpour, Mahdi
    Jabbari, Parnian
    Rezaei, Nima
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 358
  • [32] Hyponatraemia in Guillain-Barre syndrome revisited
    Hiew, F. L.
    Winer, J. B.
    Rajabally, Y. A.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (04): : 295 - 301
  • [33] Intravenous immunoglobulin for Guillain-Barre syndrome
    Hughes, Richard A. C.
    Swan, Anthony V.
    van Doorn, Pieter A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [34] Guillain-Barre syndrome: A comprehensive review
    Bellanti, Roberto
    Rinaldi, Simon
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (08)
  • [35] Intravenous immunoglobulin for Guillain-Barre syndrome
    Hughes, Richard A. C.
    Swan, Anthony V.
    van Doorn, Pieter A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [36] THE ROLE OF CHEMOKINES IN GUILLAIN-BARRE SYNDROME
    Chiang, Sharon
    Ubogu, Eroboghene E.
    MUSCLE & NERVE, 2013, 48 (03) : 320 - 330
  • [37] Intravenous immunoglobulin for Guillain-Barre syndrome
    Hughes, Richard A. C.
    Swan, Anthony V.
    van Doorn, Pieter A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (07):
  • [38] A unicenter, prospective study of Guillain-Barre syndrome in Spain
    Sedano, Maria J.
    Orizaola, Pedro
    Gallardo, Elena
    Garcia, Antonio
    Pelayo-Negro, Ana L.
    Sanchez-Juan, Pascual
    Infante, Jon
    Berciano, Jose
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 139 (06): : 546 - 554
  • [39] A Guillain-Barre syndrome variant with prominent facial diplegia
    Susuki, Keiichiro
    Koga, Michiaki
    Hirata, Koichi
    Isogai, Emiko
    Yuki, Nobuhiro
    JOURNAL OF NEUROLOGY, 2009, 256 (11) : 1899 - 1905
  • [40] Biological Drugs in Guillain-Barre Syndrome: An U pdate
    Motamed-Gorji, Nazgol
    Matin, Nassim
    Tabatabaie, Omidreza
    Pavone, Piero
    Romano, Catia
    Falsaperla, Raffaele
    Vitaliti, Giovanna
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (07) : 938 - 950